Celleron Therapeutics Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding, Subsidiary
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer
Phase 1
- Conditions
- Colorectal Neoplasms Malignant
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Celleron Therapeutics Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT03993626
- Locations
- 🇬🇧
Celleron Therapeutics Ltd, Oxford, Oxfordshire, United Kingdom
News
No news found